This study adhered to the human experimentation guidelines of the Helsinki Declaration and was approved by the institutional review boards of the CDC and Emory University, Atlanta. All subjects gave informed consent. The study enrolled subjects who had participated from 1997 through 2000 in the Wichita CFS Surveillance Study.2,32 A random-digit-dialing telephone survey was used to screen 56 146 adult residents, 18 to 69 years of age, living in Wichita in 1997. Based on the screening survey, a total of 5295 persons with fatigue of 1 month's duration or longer were identified. These persons were contacted to participate in a detailed telephone interview, and 3528 agreed to participate, along with a subset of 3634 nonfatigued (NF) persons. The detailed interview was used to identify cases with fatigue for 6 months or longer, who did not feel better after rest, who did not report any fatigue-associated medical or psychiatric conditions, and who reported at least 4 of the 8 CFS case-defining symptoms (CFS-like cases). A total of 555 CFS-like cases were identified and invited to participate in a clinical examination to confirm CFS. Of those, 299 agreed to participate. Participants and nonparticipants did not differ in age, sex, income, and duration of illness.2 Randomly selected NF persons matched to CFS-like cases based on age, sex, race, and body mass index (calculated as weight in kilograms divided by height in meters squared) were also invited to undergo the same tests to confirm their status and rule out other conditions. All persons who participated in the baseline clinical evaluation and had no permanent exclusion were invited to complete follow-up detailed telephone interviews in 1998, 1999, and 2000, along with persons whose status had changed over time, making them eligible for a detailed interview in subsequent years. Among eligible persons, interviews were conducted with 4228 in 1998, 3980 in 1999, and 3474 in 2000, representing 69%, 65%, and 56% of the original sample, respectively. Among eligible subjects who completed detailed interviews, 67% completed clinical evaluations at 12 months, 70% at 24 months, and 68% at 36 months of follow-up. The study yielded information on prevalence, incidence, and clinical course of CFS as described elsewhere.2,33